The US Department of Defense and Deinove will present impactful R&D results during the coming ASM 2019
(WorldNews Africa)

L`USAMRIID (United States Army Medical Research Institute of Infectious Diseases) evaluated DNV3681 against Bacillus anthracis that triggers anthrax and Francisella tularensis that triggers tularemia or rabbit fever, both bacteria being classified in the `high priority` category of biothreat agents DNV3681 demonstrated a superior in vitro efficacy compared to Ciprofloxacin which is the product of reference when exposed to Bacillus anthracis These data...